Brief: EXPAND Expand Trial Of Natera's Fetal Focus Single-Gene Nipt Surpasses >2,000 Patients Enrolled
20/05/2026 12:09
May 20 (Reuters) - Natera Inc NTRA.O: EXPAND TRIAL OF NATERA’S FETAL FOCUS™ SINGLE-GENE NIPT SURPASSES >2,000 PATIENTS ENROLLED Source text: ID:nBw5K0K6ra Further company coverage: NTRA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Natera
See all newsBrief: FDA Grants Breakthrough Device Designation For Natera’S Multi-Cancer Early Detection Assay
Brief: Alliance Foundation Trials And Natera Announce Aft-70 Navigate A Global, Randomized, Phase Iii Trial Evaluating Genentech’S Oral Selective Estrogen Receptor Degrader With Signatera Mrd-Guided Cdk4/6 Inhibitor Therapy In Breast Cancer
US RESEARCH ROUNDUP-Chevron, Exxon Mobil, GoDaddy
Brief: Natera Says Signatera Commercial Launch In Japan Expected In 1H 2027
Brief: Natera To Support New Clinical Trial Assessing Ctdna Dynamics With Latitud In Advanced Skin Cancers